AzTrials
AzTrials

PTSDNCT02917447

Evaluation of Web-Based CBT for Women Veterans With PTSD

A study testing DESTRESS-WV and Phone Monitoring in people with PTSD, run by VA Office of Research and Development at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate an online PTSD intervention that was adapted for women Veterans, called DElivery of Self TRaining and Education for Stressful Situations-Women Veterans version (DESTRESS-WV). Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
PTSD
What is being tested?
DESTRESS-WV and Phone Monitoring
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
102 participants
Where
1 siteUnited States
Study dates
5 Jul 2016to 28 Jun 2019
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • age 18 or older
  • female
  • Veteran of the US military
  • current PTSD
  • reports routine access to computer and Internet
  • willing to provide at least one collateral contact
  • willing to allow investigators to leave phone messages pertaining to the study
  • willing to be audio-taped during assessments and study coach calls

Who cannot join

  • actively engaged in individual therapy in the past two months, or receiving couple's or group therapy in the past two months that focuses on PTSD
  • scheduled to receive a future individual therapy appointment or future couples' or group therapy appointment focused on PTSD at a frequency of once per month or more
  • active suicidal or violent ideation within the past two months or on the VA "high risk" list for imminent danger to self or others
  • moderate or extreme substance use disorder in the past year
  • acute psychosis, psychotic episode, or psychotic disorder diagnosis within the past year
  • unstable administration schedule or dosing of any antidepressant, anxiolytic, or sedative-hypnotic

Trial locations and contacts

1 site in 1 country.

United States1 site
  • VA Puget Sound Health Care System Seattle Division, Seattle, WA

    Seattle, Washington, 98108

Other trials in United States

About this study

The purpose of this study is to evaluate an online PTSD intervention that was adapted for women Veterans, called DElivery of Self TRaining and Education for Stressful Situations-Women Veterans version (DESTRESS-WV). The intervention consists of structured online sessions as well as weekly brief phone calls for additional support with a study coach. Women Veterans with PTSD who are eligible will be randomized to receive either DESTRESS-WV or phone monitoring only for 8 weeks. Participants will be assessed immediately post-treatment as well as at 12 and 24 weeks post-treatment. Investigators hypothesize that participants randomly assigned to DESTRESS-WV will have a greater decrease in severity of PTSD symptoms compared to those randomly assigned to phone monitoring only.

Read the detailed description

The RCT will target women Veterans with PTSD to compare the adapted, web-based intervention to phone monitoring only. Participants will include women Veterans with PTSD who are not actively receiving PTSD treatment. They will be interviewed via phone for an initial phone screening and eligibility interview and will complete additional online surveys at baseline, post-treatment, and 12-, and 24-week follow-up.

Recruitment. Women Veterans who live in Pacific or Mountain Time Zones with an ICD code for PTSD or a positive VA mandated PTSD screen, with no mental health stop-code in the last 2 months, and who are not on the high risk list for imminent danger to self or others, will be identified using a VINCI data pull. Individuals with these criteria will be mailed up to two invitation letters and a brochure describing the study inviting them to contact the study office. If women do not contact the study office to opt out of the study, the investigators may call them to follow-up. The investigators aim to obtain a sample of 100 individuals that meet study inclusion/exclusion criteria after providing informed consent. Because the investigators aim to recruit participants for approximately 24 months, the investigators will aim to enroll and randomize 4-5 participants per month.

Procedure. The RCT will involve four assessment phases: initial phone screen to ascertain interest and basic inclusion/exclusion eligibility, assessment of diagnostic eligibility in a full eligibility interview, baseline survey of outcomes of interest prior to initiating treatment, and three follow-up surveys of outcomes of interest at post-treatment and 12- and 24-weeks post-treatment. Patients will be randomized to condition following completion of the baseline online survey. The eligibility interview and study coach phone calls will be audio-recorded to ensure adherence to the study protocol.

Phone screen (10-15 minutes). When interested women Veterans contact the study office, study personnel will provide an overview of the study and, for those still interested, conduct an initial pre-consent screening. The purpose of the pre-consent eligibility screening is to quickly determine which candidates are most likely to qualify, thus eliminating the need to conduct consent and full eligibility interviews for those who are unlikely to meet study criteria. If patients are found to be eligible following the pre-consent eligibility screening, study staff will review the consent process, including willingness to be audio-taped during assessments and study coach calls, answer any questions, and mail the consent form to the participant to obtain written consent, along with a demographic form and Life Events Checklist. The full eligibility interview will be scheduled at this time but will only be conducted if and when the signed, written informed consent, HIPAA form, demographic form, and Life Events Checklist have been received in the study office.

Eligibility interview (95-150 minutes). Study personnel will call the potential study participant to conduct the eligibility interview over the phone after written, informed consent has been received in the study office. The interview will assess current PTSD as addressed by the CAPS interview as well as various exclusion criteria. During the course of the interview, if study personnel are concerned about the fit of the study for the potential participant, they will discuss with the PI. Potential participants who are of concern and may show a high risk profile (e.g., multiple past suicide attempts, inpatient hospitalizations, lifetime psychotic disorders) or prominent disorganization while on the phone will be discussed by the PI and co-investigator Dr. Simpson for possible exclusion.

Respondents who do not meet eligibility criteria will be offered a resource list, referred for treatment, and/or be further assessed for suicidality as appropriate. For those who are eligible, contact information (e.g., address, telephone number) and contact information for at least one friend or family member who typically would know the whereabouts of the participant should study staff have difficulty making contact will be recorded. Eligible patients will be invited to complete a baseline online survey.

Baseline and follow-up online surveys (60-90 minutes). The baseline and follow-up surveys (at post-treatment and 12- and 24-week follow-ups) consist of an online survey. Each online survey takes 60-90 minutes to complete. Participants will be compensated for the baseline survey, for each of the follow-up surveys, and a bonus for completing all surveys. If the interval between the eligibility interview and baseline survey is longer than four weeks, we will require re-administration of CAPS via telephone to ensure PTSD status. Participants will be given one-week and one-day reminders to complete the survey. Following completion of the baseline survey, participants will be randomly assigned to one of the conditions.

Randomization scheme. Fifty participants will be randomized to the adapted, web-based intervention and 50 to phone monitoring only. Participants will be randomized following their completion of the baseline survey. Stratification of randomization by rural status will be done to facilitate exploratory analyses of the impact of this variable on trial outcomes. Following randomization, the study coach will arrange an initial telephone session with each participant.

Study conditions. The treatment phase for both study conditions will last 8 weeks; however, participants will have up to 12 weeks to complete the intervention and complete study coach calls, if needed.

Phone monitoring condition. Participants randomized to the phone monitoring condition will receive calls from a study coach once a week for 8 weeks for approximately 10-15 minutes. The coach will assess their PTSD symptoms and safety.

DESTRESS-WV. Those randomly assigned to the web-based intervention will also receive calls from a study coach once a week for 8 weeks to assess PTSD symptoms and safety; the coach will also review the participant's progress with the DESTRESS-WV website. Participants will be instructed to log-on to the website twice per week, with each session taking approximately 30-60 minutes. The web-based intervention consists of 16 sessions involving structured, cognitive-behavioral components, including cognitive restructuring and in-vivo and imaginal exposure. Participants will be reminded of the study office phone number as well as the Veterans Crisis Line phone number at every logon.

Conditions
PTSD
Being tested
DESTRESS-WV, Phone Monitoring
Keywords
PTSD, Women Veterans, Online intervention
Medical subject headings
Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • DESTRESS-WVBehavioural

    This is an online intervention for PTSD tailored for women Veterans. The intervention is based on cognitive behavioral therapy (CBT). The goal of CBT is to help people recognize and address their thoughts and behaviors in positive ways with the aim of improving their ability to function as well as possible in their lives. Participants will be asked to log on to the website twice per week for about 30-60 minutes each time. Homework assignments will include stress management skills that participants will be asked to practice and apply. A study coach will call each participant once a week for 8 weeks for about 15 minutes to review their progress with the program.

  • Phone MonitoringBehavioural

    A study coach will call participants once a week for 8 weeks for approximately 15 minutes. The coach will assess participants' PTSD symptoms and safety. She will encourage participants to use the time on the call to discuss any current life issues or problems that they would like. Active listening and rephrasing will be used, while teaching cognitive-behavioral strategies will be avoided.

Study groups in NCT02917447
Study groupRoleWhat they receive
DESTRESS-WVExperimentalTailored online intervention for PTSD for women Veterans with coach support.
Receives: Behavioral: DESTRESS-WV
Phone MonitoringPlacebo comparatorWeekly check-in calls from a study coach.
Receives: Behavioral: Phone Monitoring

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in PTSD Checklist (PCL-5)

    The PTSD Symptom-Checklist -Version 5 (PCL-5) is a 20-item, self-report instrument that assesses the presence and severity of DSM-V PTSD symptoms in the last month. It was summed for a total severity score ranging from 0-80, with higher scores representing greater symptom severity. Changes from baseline at three separate times post-baseline are reported for each treatment group. These calculations are based on marginal means estimated from a linear mixed model analysis with PCL as the dependent variable; rural status, MST history, study assessment, treatment group, and study assessment by treatment group interaction as the independent fixed effects; and study participant as a random effect.

    Measured: Baseline, Post-treatment (8-12 weeks after baseline), 3-months post-treatment, 6-months post-treatment

Secondary outcomes (2)
  1. Change in Patient Health Questionnaire-8 (PHQ-8)

    The Patient Health Questionnaire-8 (PHQ-8) is a brief self-report assessment of common mental disorders and was used to assess symptoms of depression. The eight items specifically correspond to symptom-based diagnostic criteria in DSM-IV and are summed for a range from 0-24, with a score of 10 or greater indicating major depression. Changes from baseline at three separate times post-baseline are reported for each treatment group. These calculations are based on marginal means estimated from a linear mixed model analysis with PHQ-8 as the dependent variable; rural status, MST history, study assessment, treatment group, and study assessment by treatment group interaction as the independent fixed effects; and study participant as a random effect.

    Measured: Baseline, Post-treatment (8-12 weeks after baseline), 3-months post-treatment, 6-months post-treatment

  2. Change in the Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form

    The Quality of Life (QoL) Enjoyment and Satisfaction Questionnaire - Short Form (Q-LES-Q-SF) was used to assess quality of life. It consists of 16 items that are summed and transformed to a scale ranging from 0-100, with higher scores indicating greater quality of life. Changes from baseline at three separate times post-baseline are reported for each treatment group. These calculations are based on marginal means estimated from a linear mixed model analysis with QoL as the dependent variable; rural status, MST history, study assessment, treatment group, and study assessment by treatment group interaction as the independent fixed effects; and study participant as a random effect.

    Measured: Baseline, Post-treatment (8-12 weeks after baseline), 3-months post-treatment, 6-months post-treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Sep 2016 (estimated)
  2. Study start5 Jul 2016
  3. Primary completion28 Jun 2019
  4. Study completion28 Jun 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
102 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02917447
Sponsor's protocol ID
MHBA-021-13SB
Other IDs
IK2CX000867-01
Status last verified
Apr 2020
First submitted
23 Sep 2016
Last updated
11 May 2020
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Lehavot K, Litz B, Millard SP, Hamilton AB, Sadler A, Simpson T. Study adaptation, design, and methods of a web-based PTSD intervention for women Veterans. Contemp Clin Trials. 2017 Feb;53:68-79. doi: 10.1016/j.cct.2016.12.002. Epub 2016 Dec 8.

    PubMed 27940187
  • Engel CC, Litz B, Magruder KM, Harper E, Gore K, Stein N, Yeager D, Liu X, Coe TR. Delivery of self training and education for stressful situations (DESTRESS-PC): a randomized trial of nurse assisted online self-management for PTSD in primary care. Gen Hosp Psychiatry. 2015 Jul-Aug;37(4):323-8. doi: 10.1016/j.genhosppsych.2015.04.007. Epub 2015 Apr 13.

    PubMed 25929985
  • Litz BT, Engel CC, Bryant RA, Papa A. A randomized, controlled proof-of-concept trial of an Internet-based, therapist-assisted self-management treatment for posttraumatic stress disorder. Am J Psychiatry. 2007 Nov;164(11):1676-83. doi: 10.1176/appi.ajp.2007.06122057.

    PubMed 17974932
  • Lehavot K, Katon JG, Chen JA, Fortney JC, Simpson TL. Post-traumatic Stress Disorder by Gender and Veteran Status. Am J Prev Med. 2018 Jan;54(1):e1-e9. doi: 10.1016/j.amepre.2017.09.008.

    PubMed 29254558
  • Chen JA, Shofer J, Barnes ML, Livingston WS, Upham M, Simpson TL. Military Sexual Trauma As a Risk Factor for Treatment Non-Response from an Online, Self-Management Posttraumatic Stress Disorder Treatment for Women Veterans. J Interpers Violence. 2024 May;39(9-10):2214-2237. doi: 10.1177/08862605231216722. Epub 2023 Dec 11.

    PubMed 38073465
  • Simon N, Robertson L, Lewis C, Roberts NP, Bethell A, Dawson S, Bisson JI. Internet-based cognitive and behavioural therapies for post-traumatic stress disorder (PTSD) in adults. Cochrane Database Syst Rev. 2021 May 20;5(5):CD011710. doi: 10.1002/14651858.CD011710.pub3.

    PubMed 34015141
  • Lehavot K, Millard SP, Thomas RM, Yantsides K, Upham M, Beckman K, Hamilton AB, Sadler A, Litz B, Simpson T. A randomized trial of an online, coach-assisted self-management PTSD intervention tailored for women veterans. J Consult Clin Psychol. 2021 Feb;89(2):134-142. doi: 10.1037/ccp0000556.

    PubMed 33705169

Questions about this trial

What is this clinical trial studying?

A study testing DESTRESS-WV and Phone Monitoring in people with PTSD, run by VA Office of Research and Development at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 May 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 11 May 2020). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in PTSD Checklist (PCL-5) (time frame: Baseline, Post-treatment (8-12 weeks after baseline), 3-months post-treatment, 6-months post-treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02917447, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 May 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in